ARTICLE | Clinical News
Andrulis Pharmaceuticals Corp. regulatory update
May 30, 1995 7:00 AM UTC
Andrulis's thalidomide product received Orphan Drug designation to prevent and treat recurrent aphthous ulcers (canker sores) in severely, terminally immunocompromised patients. Privately held Andruli...